Australia, April 24 -- Quince Therapeutics Inc., owns the trademark (2345587) for 'QUINCE' till Oct. 27, 2032.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical, medicinal and biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), autoimmune disease (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), inflammatory disease (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), diabetes, cancer, periodont...